Golimumab
Quick Overview
| Attribute | Value |
|---|---|
| Drug Name | Golimumab |
| DrugBank ID | DB06674 |
| KG Predictions | 12 |
| DL Predictions (≥0.7) | 87 |
| Evidence Level | L5 |
| NPRA Status | Approved |
Sample Brand Names in Malaysia
Predicted Indications
This drug has 12 knowledge graph predictions and 87 high-confidence deep learning predictions.
Top KG Predictions
| Indication | Source |
|---|---|
| inflammatory bowel disease | KG |
| spondyloarthropathy, susceptibility to | KG |
| rheumatoid arthritis | KG |
| ankylosing spondylitis | KG |
| psoriatic arthritis | KG |
| ulcerative colitis (disease) | KG |
| inflammatory bowel disease | KG |
| spondyloarthropathy, susceptibility to | KG |
| rheumatoid arthritis | KG |
| ankylosing spondylitis | KG |
FHIR Resources
Access drug data via FHIR R4 API:
- MedicationKnowledge:
/fhir/MedicationKnowledge/DB06674
Related Resources
| Resource | Link |
|---|---|
| DrugBank | View on DrugBank |
| PubMed | Search PubMed |
| ClinicalTrials.gov | Search Trials |
Disclaimer
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.